Package | hl7.eu.fhir.flute |
Type | StructureDefinition |
Id | LM-InclusionCriterias |
FHIR Version | R4 |
Source | http://hl7.eu/fhir/ig/flute/https://build.fhir.org/ig/hl7-eu/flute/StructureDefinition-LM-InclusionCriterias.html |
URL | http://hl7.eu/fhir/ig/flute/StructureDefinition/LM-InclusionCriterias |
Version | 0.1.0 |
Status | draft |
Date | 2025-04-24T09:01:03+00:00 |
Name | InclusionCriterias |
Title | Inclusion Criteria for Prostate Cancer Cohorts |
Realm | eu |
Authority | hl7 |
Description | Criteria for including men in cohorts based on clinical suspicion of prostate cancer. |
Type | http://hl7.eu/fhir/ig/flute/StructureDefinition/LM-InclusionCriterias |
Kind | logical |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: StructureDefinition LM-InclusionCriterias
Name | Flags | Card. | Type | Description & Constraints |
---|---|---|---|---|
![]() ![]() | 0..* | Base | Inclusion Criteria for Prostate Cancer Cohorts | |
![]() ![]() ![]() | 0..1 | Quantity | Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml. | |
![]() ![]() ![]() | 0..1 | integer | Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious). | |
{ "resourceType": "StructureDefinition", "id": "LM-InclusionCriterias", "text": { "status": "extensions", "div": "<!-- snip (see above) -->" }, "url": "http://hl7.eu/fhir/ig/flute/StructureDefinition/LM-InclusionCriterias", "version": "0.1.0", "name": "InclusionCriterias", "title": "Inclusion Criteria for Prostate Cancer Cohorts", "status": "draft", "date": "2025-04-24T09:01:03+00:00", "publisher": "Flute Project", "contact": [ { "name": "Flute Project", "telecom": [ { "system": "url", "value": "https://www.fluteproject.eu/" } ] }, { "name": "Flute Project", "telecom": [ { "system": "url", "value": "https://www.fluteproject.eu/" } ] } ], "description": "Criteria for including men in cohorts based on clinical suspicion of prostate cancer.", "fhirVersion": "4.0.1", "mapping": [ { "identity": "InclusionCriteriasToFHIR", "uri": "http://hl7.org/fhir/r4", "name": "Prostate Cancer Study Variables to FHIR R4 Profiles" } ], "kind": "logical", "abstract": false, "type": "http://hl7.eu/fhir/ig/flute/StructureDefinition/LM-InclusionCriterias", "baseDefinition": "http://hl7.org/fhir/StructureDefinition/Base", "derivation": "specialization", "snapshot": { "extension": [ { "url": "http://hl7.org/fhir/tools/StructureDefinition/snapshot-base-version", "valueString": "4.0.1" } ], "element": [ { "id": "LM-InclusionCriterias", "path": "LM-InclusionCriterias", "short": "Inclusion Criteria for Prostate Cancer Cohorts", "definition": "Criteria for including men in cohorts based on clinical suspicion of prostate cancer.", "min": 0, "max": "*", "base": { "path": "Base", "min": 0, "max": "*" }, "isModifier": false, "mapping": [ { "identity": "InclusionCriteriasToFHIR", "map": "FHIR R4" } ] }, { "id": "LM-InclusionCriterias.psa", "path": "LM-InclusionCriterias.psa", "short": "Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml.", "definition": "Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml.", "min": 0, "max": "1", "base": { "path": "LM-InclusionCriterias.psa", "min": 0, "max": "1" }, "type": [ { "code": "Quantity" } ], "mapping": [ { "identity": "InclusionCriteriasToFHIR", "map": "Observation.where(code = 'http://loinc.org|2857-1').value" } ] }, { "id": "LM-InclusionCriterias.dre", "path": "LM-InclusionCriterias.dre", "short": "Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious).", "definition": "Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious).", "min": 0, "max": "1", "base": { "path": "LM-InclusionCriterias.dre", "min": 0, "max": "1" }, "type": [ { "code": "integer" } ], "mapping": [ { "identity": "InclusionCriteriasToFHIR", "map": "Procedure.where(code = 'http://snomed.info/sct|410006001').outcome" } ] } ] }, "differential": { "element": [ { "id": "LM-InclusionCriterias", "path": "LM-InclusionCriterias", "short": "Inclusion Criteria for Prostate Cancer Cohorts", "definition": "Criteria for including men in cohorts based on clinical suspicion of prostate cancer.", "mapping": [ { "identity": "InclusionCriteriasToFHIR", "map": "FHIR R4" } ] }, { "id": "LM-InclusionCriterias.psa", "path": "LM-InclusionCriterias.psa", "short": "Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml.", "definition": "Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml.", "min": 0, "max": "1", "type": [ { "code": "Quantity" } ], "mapping": [ { "identity": "InclusionCriteriasToFHIR", "map": "Observation.where(code = 'http://loinc.org|2857-1').value" } ] }, { "id": "LM-InclusionCriterias.dre", "path": "LM-InclusionCriterias.dre", "short": "Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious).", "definition": "Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious).", "min": 0, "max": "1", "type": [ { "code": "integer" } ], "mapping": [ { "identity": "InclusionCriteriasToFHIR", "map": "Procedure.where(code = 'http://snomed.info/sct|410006001').outcome" } ] } ] } }